Literature DB >> 12088280

Cyclooxygenase, lipoxygenase and tumor angiogenesis.

D Nie1, K V Honn.   

Abstract

Arachidonic acid metabolism through cyclooxygenase (COX) and lipoxygenase (LOX) pathways generates various biologically active lipids that play important roles in inflammation, thrombosis and tumor progression. Angiogenesis, the formation of new capillary vessels from preexisting ones, underpins a number of physiological processes and participates in the development of several pathological conditions such as arthritis, cancer and various eye diseases. The formation of new capillary vessels is a multistep process that involves endothelial cell proliferation, migration and tube formation. In the present review, we survey the literature on the regulation of angiogenesis by arachidonate metabolites, especially those from the COX and 12-LOX pathways in the context of tumor growth, and put forward some unanswered but important questions for future studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088280     DOI: 10.1007/s00018-002-8468-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  30 in total

Review 1.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling.

Authors:  A Fiorio Pla; H L Ong; K T Cheng; A Brossa; B Bussolati; T Lockwich; B Paria; L Munaron; I S Ambudkar
Journal:  Oncogene       Date:  2011-06-20       Impact factor: 9.867

Review 3.  Aspirin, cyclooxygenase inhibition and colorectal cancer.

Authors:  Carlos Sostres; Carla Jerusalen Gargallo; Angel Lanas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

Review 4.  The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.

Authors:  Prasanna Ekambaram; Wanyu Lambiv; Rosanna Cazzolli; Anthony W Ashton; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

5.  Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells.

Authors:  Andries Zijlstra; Marco Seandel; Tatyana A Kupriyanova; Juneth J Partridge; Mark A Madsen; Elizabeth A Hahn-Dantona; James P Quigley; Elena I Deryugina
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

6.  Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.

Authors:  Qian Liu; Bo Tao; Guizhu Liu; Guilin Chen; Qian Zhu; Ying Yu; Yu Yu; Hong Xiong
Journal:  J Biol Chem       Date:  2016-01-02       Impact factor: 5.157

7.  Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.

Authors:  Vidudala V T S Prasad; Padma Kolli; Divya Moganti
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

8.  Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia.

Authors:  Yossi Issan; Edith Hochhauser; Austin Guo; Katherine H Gotlinger; Ran Kornowski; Dorit Leshem-Lev; Eli Lev; Eyal Porat; Eitan Snir; Carl I Thompson; Nader G Abraham; Michal Laniado-Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-01-03       Impact factor: 3.072

Review 9.  Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products.

Authors:  Ambra Pozzi; Roy Zent
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Sep-Oct

10.  Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic.

Authors:  Sasikumar J Soumya; Sheela Binu; A Helen; K Anil Kumar; P Reddanna; Perumana R Sudhakaran
Journal:  Inflamm Res       Date:  2012-03-27       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.